NCT01711775View on ClinicalTrials.gov

A Pharmacokinetic Study of Aleglitazar in Healthy Chinese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

aleglitazar

Single oral dose Day 1, repeated oral dose once daily Days 5-14

Trial Locations (1)

100083

Beijing

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01711775 - A Pharmacokinetic Study of Aleglitazar in Healthy Chinese Volunteers | Biotech Hunter | Biotech Hunter